Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Applied Ergonomics
|
March 3, 2009
A numerical tool for reproducing driver behaviour: experiments and predictive simulations
M Casucci, M Marchitto, P C Cacciabue
Biochimica Et Biophysica Acta
|
January 10, 2016
Clinical pharmacology of CAR-T cells: Linking cellular pharmacodynamics to pharmacokinetics and antitumor effects
M Norelli, M Casucci, C Bonini, et al.
Minerva Pediatrica
|
November 25, 2010
Aminoterminal B-type natriuretic peptide (NT-proBNP) in the therapy of patent ductus arteriosus
F Bagnoli, A Rossetti, M Casucci, et al.
Tissue Antigens
|
December 14, 2011
Genetic engineering of T cells for the immunotherapy of haematological malignancies
M Casucci, A Bondanza, L Falcone, et al.
Minerva Pediatrica
|
May 21, 2013
Is vitamin D supplementation necessary in healthy full-term breastfed infants? A follow-up study of bone mineralization in healthy full-term infants with and without supplemental vitamin D
F Bagnoli, M Casucci, S Toti, et al.
International Immunology
|
June 29, 1999
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells
U Dianzani, M Bragardo, A Tosti, et al.
Blood
|
June 25, 1999
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation
L Ruggeri, M Capanni, M Casucci, et al.
Nature Communications
|
March 28, 2024
Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus
M Doglio, A Ugolini, C Bercher-Brayer, et al.
Oncoimmunology
|
May 4, 2018
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells
V Leuci, G M Casucci, G Grignani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2022
Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
Manmeet S Ahluwalia, David A Reardon, Ajay P Abad, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Applied Ergonomics
|
March 3, 2009
A numerical tool for reproducing driver behaviour: experiments and predictive simulations
M Casucci, M Marchitto, P C Cacciabue
Biochimica Et Biophysica Acta
|
January 10, 2016
Clinical pharmacology of CAR-T cells: Linking cellular pharmacodynamics to pharmacokinetics and antitumor effects
M Norelli, M Casucci, C Bonini, et al.
Minerva Pediatrica
|
November 25, 2010
Aminoterminal B-type natriuretic peptide (NT-proBNP) in the therapy of patent ductus arteriosus
F Bagnoli, A Rossetti, M Casucci, et al.
Tissue Antigens
|
December 14, 2011
Genetic engineering of T cells for the immunotherapy of haematological malignancies
M Casucci, A Bondanza, L Falcone, et al.
Minerva Pediatrica
|
May 21, 2013
Is vitamin D supplementation necessary in healthy full-term breastfed infants? A follow-up study of bone mineralization in healthy full-term infants with and without supplemental vitamin D
F Bagnoli, M Casucci, S Toti, et al.
International Immunology
|
June 29, 1999
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells
U Dianzani, M Bragardo, A Tosti, et al.
Blood
|
June 25, 1999
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation
L Ruggeri, M Capanni, M Casucci, et al.
Nature Communications
|
March 28, 2024
Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus
M Doglio, A Ugolini, C Bercher-Brayer, et al.
Oncoimmunology
|
May 4, 2018
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells
V Leuci, G M Casucci, G Grignani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2022
Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
Manmeet S Ahluwalia, David A Reardon, Ajay P Abad, et al.
Page
of 1